This site uses cookies to improve user experience by collecting data. By continuing to use this website, you agree to the use of cookies and similar technologies as described in our Privacy Policy.
CONFIRM

ACC

Program
Discovery
Preclinical
Phase I
Phase II
ACE1702
HER2 Targeting, ACC-oNK Cell Therapy
Phase I ​
ACE1975
CD70 Targeting, ACC-oNK Cell Therapy
Preclinical ​
ACE1831
CD20 Targeting, ACC-γδ T Cell Therapy
Preclinical ​
ACE1708
PD-L1 Targeting, ACC-oNK Cell Therapy
Preclinical ​

CAR

Program
Discovery
Preclinical
Phase I
Phase II
ACE1755 (Safety+)
CD19 Targeting, CAR-oNK Cell Therapy
Preclinical ​
We have collaborated with biopharmaceutical partners and academic institutes worldwide.